The diagnostic and prognostic value of LncRNA FAM3D-AS1 expression in nasopharyngeal carcinoma and its effect on tumor progression and cisplatin resistance
LncRNA FAM3D-AS1 can be used as a biomarker to diagnose and prognosticate NPC. LncRNA FAM3D-AS1 affects tumor progression and cisplatin resistance in NPC.
Authors
- Bohan Zhang (ORCID: https://orcid.org/0000-0003-0337-1002)
- Zixiao Chen
- Zhinong Wu
Institutions
- Xianning Central Hospital (CN)
Publication Details
- Journal
- Hereditas
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1186/s41065-025-00526-0
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00